Evidence map›Paper›PMID 38330274›Full record

ArticleJCO global oncology2024

Expanding Access to Computed Tomographic Staging and Three-Dimensional Intensity Modulated Radiotherapy for Cervical Cancer in Ghana.

Aba Anoa Scott, Verna Vanderpuye, Mary-Ann Dadzie, Joel Yarney, Charles Akoto Aidoo, Judith Tackie, Stephen Kpatsi, Samuel Boateng, Tony Obeng-Mensah, Michael Nyamadi and 5 more

Open access · goldAbstract read
In one paragraph

Article in JCO global oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 2 countries.

Aba Anoa ScottKorle Bu Teaching Hospital, Accra, Ghana.ORCID 0000-0001-6392-2967
Verna VanderpuyeKorle Bu Teaching Hospital, Accra, Ghana.ORCID 0000-0003-3656-6965
Mary-Ann DadzieKorle Bu Teaching Hospital, Accra, Ghana.ORCID 0000-0003-4800-4724
Joel YarneyKorle Bu Teaching Hospital, Accra, Ghana.ORCID 0000-0002-4048-2935
Charles Akoto AidooKorle Bu Teaching Hospital, Accra, Ghana.
Judith TackieKorle Bu Teaching Hospital, Accra, Ghana.
Stephen KpatsiKorle Bu Teaching Hospital, Accra, Ghana.ORCID 0009-0005-8954-0509
Samuel BoatengKorle Bu Teaching Hospital, Accra, Ghana.
Tony Obeng-MensahKorle Bu Teaching Hospital, Accra, Ghana.
Michael NyamadiKorle Bu Teaching Hospital, Accra, Ghana.
Philip OdonkorKorle Bu Teaching Hospital, Accra, Ghana.
Tony LamRadiation Medicine Program, Princess Margaret Cancer Centre, Toronto, ON, Canada.
Tony TadicRadiation Medicine Program, Princess Margaret Cancer Centre, Toronto, ON, Canada.ORCID 0000-0001-7797-2893
Lian VelascoRadiation Medicine Program, Princess Margaret Cancer Centre, Toronto, ON, Canada.
Michael MilosevicRadiation Medicine Program, Princess Margaret Cancer Centre, Toronto, ON, Canada.ORCID 0000-0002-9620-6876
Korle Bu Teaching Hospital · GHUniversity of Toronto · CAPrincess Margaret Cancer Centre · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo build capacity for improved treatment of locally advanced cervical cancer in Ghana, including computed tomography (CT) staging and intensity modulated radiotherapy (IMRT). MATERIALS AND

methodsPatients with histologically confirmed cervical cancer were prospectively staged with abdominopelvic CT and ultrasound and offered the opportunity to have IMRT instead of conventional two-dimensional radiotherapy. The development of an efficient, high-quality, and safe IMRT program was facilitated by investment in new technology and comprehensive training of the interdisciplinary radiotherapy team in collaboration with a North American center of excellence.

resultsOf 215 patients with cervical cancer referred in 2022, 66% were able to afford CT scans and 26% were able to afford IMRT. Lymph node metastases were identified in 52% of patients by CT but in only 2% of patients by ultrasound. The use of CT resulted in 63% of patients being upstaged and changed treatment intent or radiation treatment volumes in 67% of patients. Patients who had IMRT experienced fewer acute side effects and were more likely to complete treatment as planned.

conclusionIt is feasible to provide state-of the-art cancer treatment with CT staging and IMRT to patients with cervical cancer in low-resource settings and achieve meaningful improvements in outcomes. It requires a broad commitment by program leadership to invest in technology and staff training. Major challenges include balancing improved clinical care with reduced patient throughput when radiation treatment capacity is constrained, and with the additional cost in the absence of universal health coverage.

Indexed as

Radiotherapy, Intensity-ModulatedUterine Cervical NeoplasmsFemaleGhanaHumansRadiotherapy DosageTomography, X-Ray Computed

Identifiers

PMID38330274
PMCPMC10861002
OpenAlexW4391637365

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.